NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
RECORDATI GROUP
St. Joseph's Hospital and Medical Center, Phoenix
Saint John's Cancer Institute
NYU Langone Health